Annals of Pediatric Cardiology is a distinguished peer-reviewed journal published by Wolters Kluwer Medknow Publications, focusing on the critical intersection of cardiology and pediatric health. Since its inception in 2008 as an Open Access journal, it has been at the forefront of disseminating significant research findings, clinical practices, and advancements in the field of pediatric cardiology. With an ISSN of 0974-2069 and an E-ISSN of 0974-5149, this journal is crucial for researchers, clinicians, and students seeking to enhance their knowledge in cardiological care for children. The journal's impact is underscored by its presence in the Q3 quartile in both Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology, and Child Health categories for 2023, demonstrating its relevance in contemporary medical research. Operating out of India, the journal addresses a gap in pediatric cardiology literature, offering a platform for high-quality research and case studies that inform clinical practice and policy.

Heart Views is a prestigious and influential journal dedicated to the field of cardiology and cardiovascular medicine, published by Wolters Kluwer Medknow Publications. With an Open Access model implemented since 2010, the journal ensures that its valuable research findings are accessible to a global audience, fostering knowledge dissemination and collaboration among researchers, professionals, and students alike. While the current impact factor is not specified, its commitment to quality and peer-reviewed content has established it as a significant resource within the cardiology community. The journal publishes a diverse array of articles, including original research, reviews, and clinical studies aimed at advancing the understanding and treatment of cardiovascular diseases. Heart Views serves as an essential platform for sharing innovative ideas and practices, thereby contributing to improved patient care and outcomes in the dynamic field of heart health.

The Egyptian Heart Journal, published by Springer, is a premier open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. As of 2023, it holds a Q3 classification within the category, showcasing its growing influence within the research community, and ranks 241 out of 387 in Scopus, reflecting a 37th percentile position. With an E-ISSN of 2090-911X, this journal has been open access since 2011, making it easily accessible to researchers, practitioners, and students alike. The journal aims to disseminate high-quality research articles, reviews, and case studies that contribute to the understanding and treatment of cardiovascular diseases. With its focus on innovative and practical solutions in cardiology, the Egyptian Heart Journal plays a critical role in shaping current and future cardiovascular research. Its global outreach and commitment to open access ensure that vital information is available to a wide audience, enhancing both scholarly discourse and clinical practice in the evolving landscape of cardiovascular medicine.

EUROPACE, published by Oxford University Press, stands at the forefront of cardiovascular and physiological research, as evidenced by its prestigious Q1 categorization in both Cardiology and Cardiovascular Medicine and Physiology (medical) for 2023. With an impressive ranking of #39 out of 387 and #14 out of 113 in the relevant Scopus categories, EUROPACE is recognized for its rigorous peer-reviewed articles that significantly contribute to advancing knowledge in heart rhythm disorders and related approaches. The journal has been operational since 1999 and will continue shaping the future of cardiovascular research until 2024, making it a vital resource for researchers, clinicians, and students alike. Through its commitment to disseminating high-quality research, EUROPACE plays a crucial role in enhancing the understanding and treatment of cardiac conditions, thereby influencing clinical practice and improving patient outcomes across the globe.

Circulation-Arrhythmia and Electrophysiology, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of cardiology and electrophysiology. With a strong emphasis on clinical and experimental research, this journal serves as a critical platform for disseminating innovative findings concerning arrhythmias and cardiac electrical activity. Operating in a highly competitive academic environment, it boasts an impressive Q1 ranking in key categories such as Cardiology and Cardiovascular Medicine, as well as Physiology (medical), positioning it within the top tier of publications in these fields. Spanning a comprehensive converged period from 2008 to 2024, Circulation-Arrhythmia and Electrophysiology offers researchers and clinicians access to cutting-edge studies that inform best practices and influence treatment protocols. Although it does not provide open access options, it remains invaluable for professionals seeking to enhance their understanding of complex electrophysiological phenomena and contribute to the evolution of cardiovascular care.

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

Congenital Heart Disease, published by TECH SCIENCE PRESS, is a pivotal academic journal focusing on the complexities of congenital heart conditions. With an ISSN of 1747-079X and an E-ISSN of 1747-0803, this journal serves as a crucial platform for researchers and healthcare professionals engaged in cardiology, pediatrics, and related fields. Established in 2006 and continuing through to 2024, it aims to disseminate insightful research findings and reviews that advance the understanding of congenital heart diseases and their management. The journal currently holds a Q4 classification in cardiology and cardiovascular medicine, with rankings in various medical categories highlighting its dedication to emerging research. Although it does not offer open access, its contributions are vital for professionals seeking to explore innovative strategies and collaborative solutions in congenital heart disease management. As it continues to navigate the evolving landscape of pediatric cardiac health, Congenital Heart Disease is committed to fostering a community of knowledge that impacts both clinical practices and academic inquiry.

Heart Rhythm O2, published by Elsevier and indexed under ISSN 2666-5018, is a premier Open Access journal that has established itself as a vital platform for the dissemination of innovative research in Cardiology and Cardiovascular Medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a distinguished Q1 ranking in its field as of 2023, underscoring its commitment to excellence and quality. Operating from its base in the Netherlands, Heart Rhythm O2 aims to bridge the gap between clinical practice and emerging scientific findings, fostering collaboration among researchers, healthcare professionals, and students globally. With a focus on high-impact original research, review articles, and clinical studies, the journal is dedicated to advancing our understanding of cardiac rhythm management and cardiovascular health. With open access options, it ensures that vital knowledge is freely available, facilitating the ongoing education and engagement of the medical community worldwide.

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.